Study Summary
This trial will study the effects of cannabis use on the endocannabinoid system (ECS) and endogenous opioid system (EOS) in adolescents. The goal is to identify biomarkers that may help distinguish youth who relapse from those who remain sober.
- Cannabis Use
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 2 Secondary · Reporting Duration: Collected at Week 8
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Contingency Management
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Contingency Management · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 14 - 25 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Colorado | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| University of Colorado Anschutz Medical Campus | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Frequently Asked Questions
Is my participation in this research endeavor permissible?
"This research endeavour is enrolling 30 adolescents and young adults who partake in cannabis consumption with a minimum frequency of twice per week. In order to be considered, all participants must lie between the ages of 14-25 years old." - Anonymous Online Contributor
Is there an age restriction for eligibility in this experiment?
"Adolescents aged 14-25 years old are welcome to apply for this clinical trial." - Anonymous Online Contributor
Has this investigation opened its doors to new participants?
"According to medical research posted on clinicaltrials.gov, this trial is actively looking for volunteers and has been open since October 13th 2022 with the latest update occurring one day later." - Anonymous Online Contributor
What is the current enrollment limit for this research initiative?
"Affirmative. Clinicaltrials.gov hosts details of this clinical trial, which was first uploaded on October 13th 2022, and is actively looking for 30 participants across a single medical centre." - Anonymous Online Contributor